Medical traumatic stress (MTS) often goes unrecognized in clinical settings, affecting up to 25% of patients following a critical illness.
These psychological responses, which can mirror traditional posttraumatic stress disorder (PTSD), frequently emerge from the ongoing internal threat of chronic disease or the experience of invasive medical procedures.
While MTS is not a formal diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), it describes trauma-related symptoms arising during or after serious medical events, according to a case study published in the Primary Care Companion for CNS Disorders. Patients who meet the full criteria for PTSD following a medical event are categorized as having medical PTSD (mPTSD).
Unlike traditional PTSD, which typically involves a threat from the past, mPTSD often stems from an enduring somatic threat. Patients must navigate the psychological impact of their condition while managing the reality of ongoing medical deterioration or chronic illness. Symptoms include intrusive memories, flashbacks, avoidance of medical settings, and hyperarousal, which can be misidentified as somatic complaints or general anxiety.
The risk for trauma-related symptoms varies significantly depending on the medical context. Data indicates that approximately 32% of patients who experience a sudden cardiac arrest report significant PTSD symptoms, while 20% develop the condition following shocks from an implantable cardioverter defibrillator. Among solid organ transplant recipients, the cumulative incidence of transplant-specific PTSD ranges from 10% to 17%.
"Serious illness, recurrent treatments, persistent symptoms, and fear of disease recurrence mean that the source of danger often remains present rather than resolved," the authors noted in the Primary Care Companion for CNS Disorders. In some cases, the experience of being treated in an intensive care unit (ICU) produces rates of PTSD similar to or higher than those observed in combat veterans.
Because patients rarely identify these symptoms themselves, clinicians are encouraged to use validated screening tools. The Society of Critical Care Medicine recommends serial screenings within two to four weeks following hospital discharge to capture symptoms early.
In primary care, the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) serves as a practical, five-item initial assessment tool. While the PC-PTSD-5 is designed for screening, the PTSD Checklist for DSM-5 (PCL-5) is used to monitor symptom severity and treatment response over time.
Clinicians often pair these tools with open-ended questions about a patient’s experience with medical appointments to better understand how memories of past procedures affect current behavior and health.
The development of mPTSD is influenced by both baseline vulnerabilities and the subjective experience of care. Preexisting trauma, depression, anxiety, and early childhood adversity are known risk factors. During a medical crisis, the most consistent predictor of mPTSD is peritraumatic dissociation, where a patient feels detached from their body or experiences fragmented memories.
Environmental factors during recovery also affect outcomes. Poor perceived social support and frequent, painful reminders of illness can exacerbate the condition.
Related reading